Phosphoinositide 3-kinase γ Regulates Cardiac Contractility by Locally Controlling Cyclic Adenosine Monophosphate Levels

Trends in Cardiovascular Medicine

Volumn 16, Issue 7, 2006, Pages 250-256

  Kerfant, Benoit Gilles ^a   Rose, Robert A ^a   Sun, Hui ^a   Backx, Peter H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE ALPHA; PHOSPHOINOSITIDE 3 KINASE GAMMA; UNCLASSIFIED DRUG;

APOPTOSIS; CALCIUM CURRENT; CELL COMPARTMENTALIZATION; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL SIZE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; SARCOPLASMIC RETICULUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CALCIUM CHANNELS, L-TYPE; CELL COMPARTMENTATION; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; CYCLIC AMP; HEART DISEASES; HEART VENTRICLES; HUMANS; ISOENZYMES; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, ADRENERGIC, BETA; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

EID: 33748541922     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.04.006     Document Type: Review

References (55)

1. Alloatti G., Marcantoni A., Levi R., et al. Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level. FEBS Lett 579 (2005) 133-140
2. i. Proc Natl Acad Sci U S A 100 (2003) 940-945
3. Baillie G., Scott J., and Houslay M. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett 579 (2005) 3264-3270
4. Bauman A., and Scott J. Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo. Nat Cell Biol 4 (2002) E203-E206
5. Beavo J. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75 (1995) 725-748
6. 2+ currents in the human pathophysiologic heart: a review. Basic Res Cardiol 97 Suppl 1 (2002) 1/11-1/18
7. Bers D. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
8. Bers D., and Ziolo M. When is cAMP not cAMP? Effects of compartmentalization. Circ Res 89 (2001) 373-375
9. 2+ transport. Circ Res 93 (2003) 487-490
10. Beuckelmann D., Nabauer M., and Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85 (1992) 1046-1055
11. Bohm M., Flesch M., and Schnabel P. Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med 75 (1997) 842-848
12. Camps M., Ruckle T., Ji H., et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11 (2005) 936-943
13. Chen-Izu Y., Xiao R., Izu L., et al. G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels. Biophys J 79 (2000) 2547-2556
14. Chesley A., Lundberg M., Asai T., et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 87 (2000) 1172-1179
15. Crackower M., Oudit G., Kozieradzki I., et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110 (2002) 737-749
16. Dedkova E., Wang Y., Blatter L., et al. Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes. J Physiol 542 Pt. 3 (2002) 711-723
17. Georget M., Mateo P., Vandecasteele G., et al. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8). FASEB J 17 (2003) 1380-1391
18. Gomez A., Valdivia H., Cheng H., et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276 (1997) 800-806
19. Gwathmey J., Copelas L., MacKinnon R., et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61 (1987) 70-76
20. Hirsch E., Katanaev V., Garlanda C., et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287 5455 (2000) 1049-1053
21. Jo S., Leblais V., Wang P., et al. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circ Res 91 1 (2002) 46-53
22. 2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci U S A 93 1 (1996) 295-299
23. Keely S. Prostaglandin E1 activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force. Mol Pharmacol 15 2 (1979) 235-245
24. Kerfant B., Oudit G., and Backx P. Pi3Kgamma alters Gi activity while maintaining ICa-L and IKAch densities. 48th Annual Meeting of the Biophysical Society. Biophys J 86 1, Pt2. (2004) 296a
25. Kerfant B., Gidrewicz D., Sun H., et al. Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kgamma-deficient mice. Circ Res 96 10 (2005) 1079-1086
26. Kuschel M., Zhou Y., Cheng H., et al. G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem 274 31 (1999) 22048-22052
27. 2+ influx in cardiomyocytes. Circ Res 95 12 (2004) 1183-1190
28. Lehnart S., Wehrens X., Reiken S., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123 1 (2005) 25-35
29. Luo J., McMullen J., Sobkiw C., et al. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 25 21 (2005) 9491-9502
30. Marcantoni A., Levi R., Gallo M., et al. Phosphoinositide 3 kinaseγ (PI3Kγ) controls L-type calcium current (ICa,L) through its positive modulation of type-phosphodiestrase (PDE3). J Cell Physiol 206 2 (2006) 329-336
31. Maurice D., Palmer D., Tilley D., et al. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 64 3 (2003) 533-546
32. Mongillo M., McSorley T., Evellin S., et al. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ Res 95 1 (2004) 67-75
33. Movsesian M. PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes. Basic Res Cardiol 97 Suppl 1 (2002) I83-I90
34. Naga Prasad S., Esposito G., Mao L., et al. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 275 7 (2000) 4693-4698
35. Naga Prasad S., Barak L., Rapacciuolo A., et al. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem 276 22 (2001) 18953-18959
36. Naga Prasad S., Jayatilleke A., Madamanchi A., et al. Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat Cell Biol 7 8 (2005) 785-796
37. Netticadan T., Temsah R., Kawabata K., et al. Sarcoplasmic reticulum Ca(2+)/calmodulin-dependent protein kinase is altered in heart failure. Circ Res 86 5 (2000) 596-605
38. Nienaber J., Tachibana H., Naga Prasad S., et al. Inhibition of receptor-localized PI3K preserves cardiac {beta}-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112 7 (2003) 1067-1079
39. Oudit G., Crackower M., Eriksson U., et al. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108 17 (2003) 2147-2152
40. Oudit G., Sun H., Kerfant B., et al. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37 2 (2004) 449-471
41. Patrucco E., Notte A., Barberis L., et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118 3 (2004) 375-387
42. Pavoine C., and Defer N. The cardiac beta2-adrenergic signalling a new role for the cPLA2. Cell Signal 17 2 (2005) 141-152
43. Prasad S., Perrino C., and Rockman H. Role of phosphoinositide 3-kinase in cardiac function and heart failure. Trends Cardiovasc Med 13 5 (2003) 206-212
44. Sahu A., and Metlakunta A. Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion. J Neuroendocrinol 17 11 (2005) 720-726
45. Sasaki T., Irie-Sasaki J., Jones R., et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287 5455 (2000) 1040-1046
46. Steinberg S., and Brunton L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41 (2001) 751-773
47. Sun H., Kerfant B., Zhao D., et al. Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kα/PKB signaling. Circ Res (2006) 10.1161/01.RES.0000223321.34482.8c
48. Takahashi K., Osanai T., Nakano T., et al. Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure. Heart Vessels 16 6 (2002) 249-256
49. 2+ current in rat ventricular myocytes. Br J Pharmacol 127 1 (1999) 65-74
50. Vila Petroff M., Egan J., Wang X., et al. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 89 5 (2001) 445-452
51. Voigt P., Dorner M., and Schaefer M. Characterization of p87PiKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B. J Biol Chem 281 (2006) 9977-9986
52. + current in cat atrial myocytes. J Gen Physiol 119 1 (2002) 69-82
53. Wong W., and Scott J. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5 12 (2004) 959-970
54. 2+ cycling to augment contraction in mouse heart. J Physiol 521 Pt. 2 (1999) 351-361
55. Zhu W., Zheng M., Koch W., et al. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A 98 4 (2001) 1607-1612